Therapeutic Drug Monitoring for Dose Optimization of Infliximab in Patients With Inflammatory Bowel Disease: An Analysis of Canadian Real-World Data.|https://dx.doi.org/10.1155/cjgh/5713315
Safety and efficacy of a defined bacterial consortium, VE303, to treat HE.|https://dx.doi.org/10.1097/HC9.0000000000000650
High-dose metformin treatment to inhibit complex I during early reperfusion protects the aged mouse heart via decreased mitochondrial permeability transition pore opening.|https://dx.doi.org/10.1016/j.jpet.2024.100529
The microbiome-restorative potential of ibezapolstat for the treatment of Clostridioides difficile infection is predicted through variant PolC-type DNA polymerase III in Lachnospiraceae and Oscillospiraceae.|https://dx.doi.org/10.1128/aac.01679-24
Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol.|https://dx.doi.org/10.1136/bmjopen-2024-088449
Alterations in Methionine Cycle and Wnt/MAPK Signaling Associated with HMBi-Induced Cashmere Growth in Goats.|https://dx.doi.org/10.3390/ijms26041663
The combined dual β-lactams and diazabicyclooctane β-lactamase inhibitor is highly effective against Mycobacterium abscessus species in vitro.|https://dx.doi.org/10.1016/j.jgar.2025.02.015
